BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28939083)

  • 1. Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma.
    Li YC; Chen FP; Zhou GQ; Zhu JH; Hu J; Kang DH; Wu CF; Lin L; Wang XJ; Ma J; Sun Y
    Oral Oncol; 2017 Oct; 73():97-104. PubMed ID: 28939083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
    BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
    Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
    Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
    Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
    Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
    Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
    Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity.
    Sun PY; Chen YH; Feng XB; Yang CX; Wu F; Wang RS
    Med Sci Monit; 2018 Dec; 24():8849-8859. PubMed ID: 30524119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
    Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
    Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
    Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
    Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.
    Nanda RH; Ganju RG; Schreibmann E; Chen Z; Zhang C; Jegadeesh N; Cassidy R; Deng C; Eaton BR; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):360-366. PubMed ID: 28463155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.
    Zhang LL; Wang XJ; Zhou GQ; Tang LL; Lin AH; Ma J; Sun Y
    Sci Rep; 2015 Dec; 5():18415. PubMed ID: 26678599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
    Dong J; Ng WT; Wong CHL; Li JS; Bollen H; Chow JCH; Eisbruch A; Lee AWM; Lee VHF; Ng SP; Nuyts S; Smee R; Ferlito A
    Radiother Oncol; 2024 Jun; 195():110258. PubMed ID: 38537680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for nasopharyngeal carcinoma using simultaneously integrated boost (SIB) protocol: a comparison planning study between intensity modulated arc radiotherapy vs. intensity modulated radiotherapy.
    Liu T; Chen J; Gong G; Zhang G; Bai T; Sun T; Lu J; Ma C; Yin Y
    Technol Cancer Res Treat; 2012 Oct; 11(5):415-20. PubMed ID: 22568626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Messer JA; Mohamed AS; Hutcheson KA; Ding Y; Lewin JS; Wang J; Lai SY; Frank SJ; Garden AS; Sandulache V; Eichelberger H; French CC; Colen RR; Phan J; Kalpathy-Cramer J; Hazle JD; Rosenthal DI; Gunn GB; Fuller CD
    Radiother Oncol; 2016 Feb; 118(2):315-22. PubMed ID: 26830697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.